» Articles » PMID: 34761286

Mammalian Animal Models for Dengue Virus Infection: a Recent Overview

Overview
Journal Arch Virol
Specialty Microbiology
Date 2021 Nov 11
PMID 34761286
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Dengue, a rapidly spreading mosquito-borne human viral disease caused by dengue virus (DENV), is a public health concern in tropical and subtropical areas due to its expanding geographical range. DENV can cause a wide spectrum of illnesses in humans, ranging from asymptomatic infection or mild dengue fever (DF) to life-threatening dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Dengue is caused by four DENV serotypes; however, dengue pathogenesis is complex and poorly understood. Establishing a useful animal model that can exhibit dengue-fever-like signs similar to those in humans is essential to improve our understanding of the host response and pathogenesis of DENV. Although several animal models, including mouse models, non-human primate models, and a recently reported tree shrew model, have been investigated for DENV infection, animal models with clinical signs that are similar to those of DF in humans have not yet been established. Although animal models are essential for understanding the pathogenesis of DENV infection and for drug and vaccine development, each animal model has its own strengths and limitations. Therefore, in this review, we provide a recent overview of animal models for DENV infection and pathogenesis, focusing on studies of the antibody-dependent enhancement (ADE) effect in animal models.

Citing Articles

A Comprehensive Review of the Development and Therapeutic Use of Antivirals in Flavivirus Infection.

Tripathi A, Chauhan S, Khasa R Viruses. 2025; 17(1).

PMID: 39861863 PMC: 11769230. DOI: 10.3390/v17010074.


Progress and challenges in development of animal models for dengue virus infection.

Yuya W, Yuansong Y, Susu L, Chen L, Yong W, Yining W Emerg Microbes Infect. 2024; 13(1):2404159.

PMID: 39312399 PMC: 11423536. DOI: 10.1080/22221751.2024.2404159.


Fc-FcγR interactions during infections: From neutralizing antibodies to antibody-dependent enhancement.

Edgar J, Bournazos S Immunol Rev. 2024; 328(1):221-242.

PMID: 39268652 PMC: 11659939. DOI: 10.1111/imr.13393.


An effective pan-serotype dengue vaccine and enhanced control strategies could help in reducing the severe dengue burden in Bangladesh-A perspective.

Kayesh M, Nazneen H, Kohara M, Tsukiyama-Kohara K Front Microbiol. 2024; 15:1423044.

PMID: 39228383 PMC: 11368799. DOI: 10.3389/fmicb.2024.1423044.


Dengue virus: pathogenesis and potential for small molecule inhibitors.

Chauhan N, Gaur K, Asuru T, Guchhait P Biosci Rep. 2024; 44(8).

PMID: 39051974 PMC: 11327219. DOI: 10.1042/BSR20240134.


References
1.
Tsukiyama-Kohara K, Kohara M . Tupaia belangeri as an experimental animal model for viral infection. Exp Anim. 2014; 63(4):367-74. PMC: 4244285. DOI: 10.1538/expanim.63.367. View

2.
Mota J, Rico-Hesse R . Humanized mice show clinical signs of dengue fever according to infecting virus genotype. J Virol. 2009; 83(17):8638-45. PMC: 2738212. DOI: 10.1128/JVI.00581-09. View

3.
Althouse B, Durbin A, Hanley K, Halstead S, Weaver S, Cummings D . Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysis. Virology. 2014; 452-453:237-46. PMC: 4578724. DOI: 10.1016/j.virol.2014.01.015. View

4.
Marchette N, Halstead S, Falkler Jr W, Stenhouse A, Nash D . Studies on the pathogenesis of dengue infection in monkeys. 3. Sequential distribution of virus in primary and heterologous infections. J Infect Dis. 1973; 128(1):23-30. DOI: 10.1093/infdis/128.1.23. View

5.
Halstead S, Shotwell H, Casals J . Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. J Infect Dis. 1973; 128(1):15-22. DOI: 10.1093/infdis/128.1.15. View